235 related articles for article (PubMed ID: 27484115)
1. Osteopontin Deficiency Alters Biliary Homeostasis and Protects against Gallstone Formation.
Lin J; Lu M; Shao WQ; Chen ZY; Zhu WW; Lu L; Jia HL; Cai D; Qin LX; Chen JH
Sci Rep; 2016 Aug; 6():30215. PubMed ID: 27484115
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin deficiency protects mice from cholesterol gallstone formation by reducing expression of intestinal NPC1L1.
Lin J; Shao WQ; Chen QZ; Zhu WW; Lu L; Jia HL; Chen JH
Mol Med Rep; 2017 Aug; 16(2):1785-1792. PubMed ID: 28627641
[TBL] [Abstract][Full Text] [Related]
3. Hypothyroidism Increases Cholesterol Gallstone Prevalence in Mice by Elevated Hydrophobicity of Primary Bile Acids.
Kube I; Tardio LB; Hofmann U; Ghallab A; Hengstler JG; Führer D; Zwanziger D
Thyroid; 2021 Jun; 31(6):973-984. PubMed ID: 33231505
[No Abstract] [Full Text] [Related]
4. Deficiency of Niemann-Pick C1 protein protects against diet-induced gallstone formation in mice.
Morales MG; Amigo L; Balboa E; Acuña M; Castro J; Molina H; Miquel JF; Nervi F; Rigotti A; Zanlungo S
Liver Int; 2010 Jul; 30(6):887-97. PubMed ID: 20408952
[TBL] [Abstract][Full Text] [Related]
5. Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation.
Cheng S; Zou M; Liu Q; Kuang J; Shen J; Pu S; Chen L; Li H; Wu T; Li R; Li Y; Jiang W; Zhang Z; He J
Am J Pathol; 2017 Apr; 187(4):808-818. PubMed ID: 28283178
[TBL] [Abstract][Full Text] [Related]
6. Proteasome inhibition protects against diet-induced gallstone formation through modulation of cholesterol and bile acid homeostasis.
Lee EJ; Kim MH; Kim YR; Park JW; Park WJ
Int J Mol Med; 2018 Mar; 41(3):1715-1723. PubMed ID: 29286073
[TBL] [Abstract][Full Text] [Related]
7. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H
Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of LXR alpha, ABCG5, ABCG8, and SR-BI in the liver from normolipidemic, nonobese Chinese gallstone patients.
Jiang ZY; Parini P; Eggertsen G; Davis MA; Hu H; Suo GJ; Zhang SD; Rudel LL; Han TQ; Einarsson C
J Lipid Res; 2008 Feb; 49(2):464-72. PubMed ID: 18007013
[TBL] [Abstract][Full Text] [Related]
9. Claudin 2 deficiency reduces bile flow and increases susceptibility to cholesterol gallstone disease in mice.
Matsumoto K; Imasato M; Yamazaki Y; Tanaka H; Watanabe M; Eguchi H; Nagano H; Hikita H; Tatsumi T; Takehara T; Tamura A; Tsukita S
Gastroenterology; 2014 Nov; 147(5):1134-45.e10. PubMed ID: 25068494
[TBL] [Abstract][Full Text] [Related]
10. Hepatic cholesterol transport from plasma into bile: implications for gallstone disease.
Zanlungo S; Rigotti A; Nervi F
Curr Opin Lipidol; 2004 Jun; 15(3):279-86. PubMed ID: 15166783
[TBL] [Abstract][Full Text] [Related]
11. Triglycerides and gallstone formation.
Smelt AH
Clin Chim Acta; 2010 Nov; 411(21-22):1625-31. PubMed ID: 20699090
[TBL] [Abstract][Full Text] [Related]
12. Activation of Estrogen Receptor G Protein-Coupled Receptor 30 Enhances Cholesterol Cholelithogenesis in Female Mice.
Wang HH; de Bari O; Arnatt CK; Liu M; Portincasa P; Wang DQ
Hepatology; 2020 Dec; 72(6):2077-2089. PubMed ID: 32112420
[TBL] [Abstract][Full Text] [Related]
13. Role of osteopontin in diet-induced brown gallstone formation in rats.
Jin CG; Jiang FR; Zhang J; Ma JR; Ling XF
Chin Med J (Engl); 2021 Apr; 134(9):1093-1100. PubMed ID: 33883409
[TBL] [Abstract][Full Text] [Related]
14. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet.
Amigo L; Quiñones V; Mardones P; Zanlungo S; Miquel JF; Nervi F; Rigotti A
Gastroenterology; 2000 Apr; 118(4):772-9. PubMed ID: 10734029
[TBL] [Abstract][Full Text] [Related]
15. Differences between hepatic and biliary lipid metabolism and secretion in genetically gallstone-susceptible and gallstone-resistant mice.
Xu G; Zhao L; Fuchs M
Chin Med J (Engl); 2002 Sep; 115(9):1292-5. PubMed ID: 12411097
[TBL] [Abstract][Full Text] [Related]
16. Prevention of cholesterol gallstone disease by schaftoside in lithogenic diet-induced C57BL/6 mouse model.
Liu M; Liu C; Chen H; Huang X; Zeng X; Zhou J; Mi S
Eur J Pharmacol; 2017 Nov; 815():1-9. PubMed ID: 28993159
[TBL] [Abstract][Full Text] [Related]
17. Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro.
Lee JH; Banerjee A; Ueno Y; Ramaiah SK
Toxicol Sci; 2008 Nov; 106(1):290-9. PubMed ID: 18703563
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion.
Hu H; Shao W; Liu Q; Liu N; Wang Q; Xu J; Zhang X; Weng Z; Lu Q; Jiao L; Chen C; Sun H; Jiang Z; Zhang X; Gu A
Nat Commun; 2022 Jan; 13(1):252. PubMed ID: 35017486
[TBL] [Abstract][Full Text] [Related]
19. Activation of liver X receptor sensitizes mice to gallbladder cholesterol crystallization.
Uppal H; Zhai Y; Gangopadhyay A; Khadem S; Ren S; Moser JA; Xie W
Hepatology; 2008 Apr; 47(4):1331-42. PubMed ID: 18318438
[TBL] [Abstract][Full Text] [Related]
20. Disruption of the murine protein kinase Cbeta gene promotes gallstone formation and alters biliary lipid and hepatic cholesterol metabolism.
Huang W; Bansode RR; Xie Y; Rowland L; Mehta M; Davidson NO; Mehta KD
J Biol Chem; 2011 Jul; 286(26):22795-805. PubMed ID: 21550971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
